Latest filing published 25 Feb 2026 for Vera Therapeutics, Inc., €176k.
Filing timeline
BuySaleInsider track record
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Sean Grant: trading record in brief
Sean Grant (finance chief) discloses dealings in Vera Therapeutics, Inc. to SEC (Form 4). In total, 37 filings cover trades dated from 6 February 2022 to 23 February 2026.
Market trades split into 7 purchases (€321k) and 20 sales (€4.5M). Sales outweigh purchases by €4.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.
The median purchase comes to €37k. Of 6 purchases, 2 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 25 February 2026 with an open-market sale (€176k) in Vera Therapeutics, Inc. The last purchase on record was published on 23 June 2023, which is 1,234 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sean Grant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,949 shares@ US$41.98399.6% of flowClass A Common StockSEC:0001872792-26-000004:0
- 25,000 shares0Class A Common StockSEC:0001872792-26-000002:0
- 26,900 shares0Class A Common StockSEC:0001415889-25-004846:0
- 14,285 shares0Class A Common StockSEC:0001415889-24-010472:0
- 99,828 shares@ US$14.8782.4% of flowClass A Common StockSEC:0001415889-24-010473:0
- 26,250 shares0Class A Common StockSEC:0001415889-24-001514:0
- 5,000 shares@ US$16.604.6% of flowClass A Common StockSEC:0001209191-23-039323:0Canonical exit: 21 Sept 2023 (T+90)
- 14,285 shares@ US$7.005.6% of flowClass A Common StockSEC:0001209191-23-010583:0Canonical exit: 7 May 2023 (T+90)
- 14,285 shares@ US$7.005.3% of flowClass A Common StockSEC:0001209191-23-007769:0Canonical exit: 7 May 2022 (T+90)
- 33,750 shares0Class A Common StockSEC:0001209191-22-047164:0
- 2,816 shares@ US$13.60082.1% of flowClass A Common StockSEC:0001209191-22-037401:0Canonical exit: 13 Sept 2022 (T+90)
11 of 11 declarations
